On Friday, Australia's biggest state New South Wales (NSW) has temporarily suspended using AstraZeneca COVID-19 after receiving an update from the government.
The suspension lasted for only a few hours after giving the patients and the vaccine receivers more updates and information.
In the same context, Australia has secured 20 million Pfizer COVID-19 vaccine doses as NSW suspended using the vaccine for hours.
AstraZeneca sparked blood clotting fears after reporting dozens of the presence of blood clots in adults who received the vaccine, on the other hand, the European Medicines Agency has listed blood clotting as one of the side effects of the AstraZeneca.